“The branded ingredients market is growing rapidly, driven by demand for clinically backed, differentiated actives”

Madhu Krishnamani, Founder and Managing Director, Botanic Healthcare

Botanic Healthcare, incorporated in 2013, is dedicated to transforming well-being by providing science-backed nutraceutical ingredients, supported by decades of expertise in R&D and a strong focus on quality. Through continued innovation and strategic global partnerships, Botanic Healthcare, having its presence in more than 50 countries, aims to unlock new growth avenues and lead the global market in the nutraceutical sector. Madhu Krishnamani, Founder and Managing Director, Botanic Healthcare, gives a glimpse of Botanic Healthcare’s plans and how it aims to revolutionise the nutraceutical industry. Edited excerpts:

Botanic Healthcare started its journey way back in 2013. How has the journey been so far since inception? What is the current status of your company?

Botanic Healthcare has been at the forefront of revolutionising the nutraceutical industry. Our journey began over a decade ago when we identified a pressing need in the market, the absence of high-quality Nutra ingredients that truly deliver healing and wellness benefits. This realisation inspired the establishment of Botanic Healthcare with a powerful mission to alleviate discomfort and enrich lives through the finest, top-class natural ingredients.Now, we are a globally recognised manufacturer of bio-active and nutraceutical ingredients and natural herbal extracts with an active presence across more than 50 countries.

Recently, Botanic Healthcare raised Rs 250 crore in funding from investors. What kind of growth are you looking for with the help of this fund in the long run?

The capital will fuel Botanic Healthcare’s aggressive expansion strategy, with the company aiming to grow by 400 per cent over the next five years. As part of its plans, Botanic Healthcare will enhance its product portfolio and forge strategic partnerships, while boosting its R&D and clinical research capabilities through joint ventures and collaborations.Botanic Healthcare’s growth vision is further supported by investments in technology, innovation, and talent acquisition. The company is focused on building a robust R&D pipeline and hiring top-tier professionals across various departments, including research, development, production, quality assurance, and sales, to effectively scale its operations.

Apart from India, you have a presence in the US, Germany, Australia, New Zealand and Korea. Which is the best-performing country out of these and why? How many staff do you have in each region?

Among our global markets, the US is currently our best-performing region due to strong demand for clean-label, science-backed nutraceuticals. Germany and South Korea are also growing rapidly, with increasing interest in plant-based and Ayurvedic solutions.We maintain lean, strategic teams across each region, focused on business development, regulatory compliance, and customer support, while core operations and R&D remain centralised in India for efficiency and consistency.

What have been the breakthroughs for Botanic Healthcare?

Some of the breakthroughs for Botanic Healthcare include:

¹Expansion to 50+ Global Markets – Establishing a strong international footprint with a presence in key regions like the US, Germany, South Korea, and Australia.

Vertically Integrated Operations – Building an end-to-end supply chain from sustainable sourcing to finished formulations, ensuring full traceability and quality control.

Clinical Research Initiatives – Launching multiple clinical trials to validate the efficacy of key botanical actives across therapeutic areas like immunity, cognition, and metabolic health.

AI-Driven Innovation – Leveraging advanced analytics and AI to accelerate the discovery of new plant-based actives and optimise formulation development.

Sustainability Leadership – Implementing eco-conscious practices across farming, extraction, and packaging—aligning with global expectations for responsible manufacturing.

How do you foresee the branded ingredients and ingredients market? Who and how many of your major clients are buying these branded ingredients? 
The branded ingredients market is growing rapidly, driven by demand for clinically backed, differentiated actives. We supply primarily to B2B clients across the US, Europe, and Asia-Pacific who value our science-backed ingredients for products targeting immunity, cognition, and metabolic health. As the industry moves towards premium, proven solutions, we see strong momentum and continued expansion.

Which are your key revenue churners?

Our primary revenue driver is our branded botanical ingredients, especially those targeting immunity, cognitive health, and metabolic wellness. While specific revenue breakdowns by sector aren’t publicly disclosed, the company’s focus on science-backed, high-efficacy ingredients has positioned it well in the global nutraceutical market. This strategic emphasis continues to fuel its expansion and innovation efforts.

How much is the export revenue? What is the percentage of revenue from the domestic market?

A significant portion of our revenue, 75 per cent, comes from international markets, reflecting our strong global footprint across the US, Europe, Asia-Pacific, and beyond. The domestic market currently contributes around 25 per cent, but is steadily growing as awareness and demand for high-quality, science-backed nutraceuticals increase in India.

Botanic Healthcare has been conducting advanced clinical research and studies on innovative ingredients. What is your current research about?

We have signed MoUs with many universities, and projects submitted and under consideration with DBT, Spice Board, Coconut Development Board and other government funding agencies. Eight clinical trials are in progress, among which three are sponsored by customers for joint work.

What will be your plans to ensure more consistent product quality and standardisation, and regulatory compliance?

We ensure consistent product quality through stringent QC protocols, in-house testing, and global GMP-certified processes. Continuous investment in R&D, regulatory expertise, and traceability systems helps us meet and exceed international compliance and standardisation benchmarks.

Sanjiv Das

sanjiv.das@mmactiv.com

1. ↩︎